DMD and Duchenne muscular dystrophy: Novel therapeutics for the treatment of DMD are currently under investigation, including additional gene replacement therapy with micro-dystrophins, gene editing approaches and membrane re-sealants (Duan, 2018; Hauck et al., 2019; Houang et al., 2018; Kyrychenko et al., 2017; Lowe et al., 2020; Yasuda et al., 2005).